Clinical Trial Update: Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years) [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of capecitabine in elderly cancer patients (≥75) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Breast Cancer, Colorectal Cancer | Phase 4 | Status: COMPLETED